Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.
about
Prodrug Strategies for PaclitaxelDesigning Dendrimer and Miktoarm Polymer Based Multi-Tasking Nanocarriers for Efficient Medical TherapyEffect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumabDevelopment of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation.Dendrimers for theranostic applications.Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells.Modular Integration of Upconverting Nanocrystal-Dendrimer Composites for Folate Receptor-Specific NIR Imaging and Light-Triggered Drug Release.Multicomponent 5-fluorouracil loaded PAMAM stabilized-silver nanocomposites synergistically induce apoptosis in human cancer cells.The new era of nanotechnology, an alternative to change cancer treatment.
P2860
Q26745997-EAC966BE-0956-4FAA-97E1-D87F055DEED2Q26782404-443E1756-49BC-4ECA-B038-B9AD92F3FE6EQ33792946-9C0C5C56-E567-4A46-9572-C4FBB770AFCBQ35209810-78E0EF29-D58A-4C3F-9464-3334468B891AQ37248679-9CC846C7-B47F-4394-B1A9-E15F68A706A8Q38542021-65F6E9CB-46ED-45D2-AAA8-4D584D31545AQ38588547-1089F5A5-F1FB-4E13-AD22-82007E5BEA80Q38796544-705D198E-AD87-4393-B0D5-942919FB7A24Q38827049-6697BCD3-865C-4E83-88A9-646BCB34DCAAQ38848214-3387EC55-9B35-4139-AFE5-C6022D6E89A5Q42370576-899FB427-ED7E-4246-A3D1-CFDB6ACDC3C5
P2860
Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Paclitaxel-conjugated PAMAM de ...... o independent modes of action.
@ast
Paclitaxel-conjugated PAMAM de ...... o independent modes of action.
@en
type
label
Paclitaxel-conjugated PAMAM de ...... o independent modes of action.
@ast
Paclitaxel-conjugated PAMAM de ...... o independent modes of action.
@en
prefLabel
Paclitaxel-conjugated PAMAM de ...... o independent modes of action.
@ast
Paclitaxel-conjugated PAMAM de ...... o independent modes of action.
@en
P2093
P2860
P50
P356
P1433
P1476
Paclitaxel-conjugated PAMAM de ...... o independent modes of action.
@en
P2093
Edgar Meyhöfer
Erika N Cline
James R Baker
Jeffrey F Herbstman
Ming-Hsin Li
Ronald G Larson
P2860
P304
P356
10.1021/BM301719B
P577
2013-02-21T00:00:00Z